Blood Pressure Status Modulates the Therapeutic Response to Sodium-Glucose Cotransporter 2 Inhibitors in Diabetic Macular Edema: A Post Hoc Subgroup Analysis of the COMET Trial.

J Diabetes · 2025 · PMC12715334 · PMID 41414742

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

a favorable trendp = 0.06so close (0.05 < p ≤ 0.1)

BCVA showed a favorable trend in the SGLT2i group, from 0.26 ± 0.25 to 0.18 ± 0.23 by week 48 ( p = 0.06) (Figure 1E ).

also in 1,335 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.